Federal grants to Eldec Pharmaceuticals, Inc.
Eldec Pharmaceuticals, Inc. in Durham, North Carolina received $4.9 million in federal grants from fiscal 2021 to 2025, across 6 awards. Its largest program was Allergy and Infectious Diseases Research, with $2.5 million. In fiscal 2025 it was awarded $280,122.
From USAspending.gov award records, updated November 7, 2026.
- Grants, FY 2021 to 2025$4.9 million
- Awards6
- Awarded in FY 2025$280,122
- Largest award$2.0 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $999,840 |
| FY 2022 | 3 | $2.3 million |
| FY 2023 | 3 | $1.3 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 1 | $280,122 |
Programs that fund Eldec Pharmaceuticals, Inc.
| Program | Awards | Amount |
|---|---|---|
| Allergy and Infectious Diseases Research | 3 | $2.5 million |
| National Center for Advancing Translational Sciences | 1 | $2.0 million |
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $280,122 |
| Cardiovascular Diseases Research | 1 | $94,743 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 6 | $4.9 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| ELD607 ORAI1 antagonist increases bacterial clearance from the lung | Allergy and Infectious Diseases Research | November 2, 2020 | $2.0 million |
| Novel strategies to clear bacteria from the cf lung - cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. Cf airways are immunocompromised and become colonized with bacteria soon after birth. Chronic bacterial infection leads to p | National Center for Advancing Translational Sciences | August 9, 2022 | $2.0 million |
| Novel peptide fusion inhibitors for the treatment of COVID-19 - project summary COVID-19 is caused by inhalation of the latest coronavirus (COV) SARS-COV-2 into the lungs, and airway epithelia are particularly susceptible to uptake this virus. Extensive evidence indicates that angiotensin converting | Allergy and Infectious Diseases Research | August 23, 2022 | $300,000 |
| Novel peptide therapeutics to treat cystic fibrosis-related diabetes - cystic fibrosis-related diabetes (CFRD) affects ~45% of cf adults and is associated with diabetic complications, increased mortality and an accelerated decline in lung function. In cfrd, proinflammatory and profibrotic responses | Diabetes, Digestive, and Kidney Diseases Extramural Research | September 12, 2025 | $280,122 |
| Novel peptide immunomodulators for treating sepsis - novel peptide immunomodulators for treating sepsis sepsis is a life-threatening clinical condition which results from a dysregulation of host immune responses to infection, which leads to multi-organ failure. Sepsis occurs in ~1.7 million us adult | Allergy and Infectious Diseases Research | May 3, 2023 | $259,121 |
| Novel strategies to clear bacteria from the cf lung - cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane regulator (CFTR) gene. Cf airways are immunocompromised and become colonized with bacteria soon after birth. Chronic bacterial infection leads to p | Cardiovascular Diseases Research | March 23, 2023 | $94,743 |
Questions people ask
How much federal grant money does Eldec Pharmaceuticals, Inc. get?
$4.9 million in 6 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Eldec Pharmaceuticals, Inc. the most?
The Department of Health and Human Services, with $4.9 million in 6 awards.
What is Eldec Pharmaceuticals, Inc.'s largest federal grant?
$2.0 million under Allergy and Infectious Diseases Research, with its first action in the period on November 2, 2020. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Eldec Pharmaceuticals, Inc.?
Its largest are Allergy and Infectious Diseases Research, National Center for Advancing Translational Sciences and Diabetes, Digestive, and Kidney Diseases Extramural Research.
Other grant recipients in Durham
- Duke University
- Family Health International
- North Carolina Central University
- Housing Authority of the City of Durham
- Rho Federal Systems Division Inc
- City of Durham
- Families & Communities Rising, Inc.
- Lincoln Community Health Center Incorporated
Largest federal grant recipients in North Carolina · Federal grants in North Carolina